Related Experiment Video
Updated: Jun 28, 2026

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Tau mutations in neurodegenerative diseases
1Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mwolfe@rics.bwh.harvard.edu
The Journal of Biological Chemistry
|October 25, 2008
Summary
Aberrant Tau protein aggregation causes neurodegenerative diseases like Alzheimer's. Understanding Tau's role and mutation mechanisms is crucial for developing effective treatments for these devastating brain conditions.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Tau deposition is a hallmark of various neurodegenerative brain diseases.
- Familial dementia linked to tau mutations confirms Tau's direct role in neurodegeneration.
- Tau pathology is strongly implicated in Alzheimer disease.
Purpose of the Study:
- To explore the mechanisms by which tau mutations lead to neurodegeneration.
- To elucidate the role of Tau in neurodegenerative conditions beyond familial dementia.
- To identify key molecular events contributing to Tau-induced neurotoxicity.
Main Methods:
- Analysis of tau mutations associated with familial dementia.
- Review of evidence supporting various molecular mechanisms of tauopathy.
- Investigation into Tau's interaction with cellular components like tubulin.
Main Results:
- Aberrant Tau can independently cause neurodegenerative disease.
- Tau mutations contribute to neurodegeneration through altered alternative splicing.
- Changes in Tau phosphorylation, tubulin interaction, and filament self-association are implicated.
Conclusions:
- Tau mutations are a direct cause of neurodegenerative diseases.
- Understanding Tau's pathogenic mechanisms is vital for Alzheimer disease research.
- Multiple molecular pathways contribute to Tau-driven neurotoxicity.
Related Concept Videos
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Mutations
Overview
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
